"10.1371_journal.pone.0092705","plos one","2014-04-01T00:00:00Z","Emily Loison; Béatrice Poirier-Beaudouin; Valérie Seffer; Audrey Paoletti; Vered Abitbol; Eric Tartour; Odile Launay; Marie-Lise Gougeon","Antiviral Immunity Biotherapy and Vaccine Unit, Institut Pasteur, Paris, France; Inserm U1030, Institut Gustave Roussy, Villejuif, France; Gastroenterology Department, Hôpital Cochin, AP-HP, Paris, France; Inserm U970, Université Paris Descartes, PARCC/HEGP, Paris, France; Centre d’Investigation Clinique BT-505, Hôpital Cochin, AP-HP, Paris, France","Conceived and designed the experiments: MLG ET. Performed the experiments: EL BPB VS AP. Analyzed the data: EL BPB VS. Wrote the paper: EL MLG. Included the patients: VA. PI of MICIVAX trial: OL.","CrossJect provided the academic research/private research partnership to fund a CIFRE fellowship used in this study. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","04","Emily Loison","EL",8,TRUE,2,4,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
